113081-51-9

Basic information

• Product Name: 2-(3-METHOXY-4-BROMOPHENYL)ETHYLAMINE
• Synonyms: 2-(3-METHOXY-4-BROMOPHENYL)ETHYLAMINE;2-(4-BroMo-3-Methoxy-phenyl)-ethylaMine;2-(4-broMo-3-Methoxyphenyl)ethanaMine;2-(4-bromo-3-methoxyphenyl)ethan-1-amine
• CAS NO: 113081-51-9
• Molecular Formula: C9H12 Br N O
• Molecular Weight: 230.1
• Mol File: 113081-51-9.mol

Chemical Properties

• Boiling Point: 303.2±27.0 °C(Predicted)
• Appearance: /
• Density: 1.385±0.06 g/cm3(Predicted)
• PKA: 9.61±0.10(Predicted)
• CAS DataBase Reference: 2-(3-METHOXY-4-BROMOPHENYL)ETHYLAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(3-METHOXY-4-BROMOPHENYL)ETHYLAMINE(113081-51-9)
• EPA Substance Registry System: 2-(3-METHOXY-4-BROMOPHENYL)ETHYLAMINE(113081-51-9)

Safety Data

• Hazardous Substances Data: 113081-51-9(Hazardous Substances Data)

Usage

Uses

Used in Research Chemicals:
2-(3-METHOXY-4-BROMOPHENYL)ETHYLAMINE is used as a research chemical for the study of its chemical properties and potential applications in various fields. It aids scientists in understanding its interactions with other compounds and its behavior under different conditions.
Used in Organic Synthesis:
In the field of organic synthesis, 2-(3-METHOXY-4-BROMOPHENYL)ETHYLAMINE is used as a precursor for the production of other compounds. Its unique structure allows it to be a valuable building block in the synthesis of various organic molecules.
Used in Pharmaceutical Development:
Although not approved for medical or therapeutic use, 2-(3-METHOXY-4-BROMOPHENYL)ETHYLAMINE may have potential applications in pharmaceutical development. Its structural features could be of interest to researchers looking for new drug candidates or exploring its possible biological activities.
Used in Legal and Regulatory Frameworks:
Due to its potential for recreational or illicit uses, 2-(3-METHOXY-4-BROMOPHENYL)ETHYLAMINE is subject to legal regulations in many jurisdictions. It is used as a reference compound in the development and enforcement of regulations concerning psychoactive substances.

Upstream product

• 113081-50-8 2-(4-bromo-3-methoxyphenyl)acetonitrile 
• 1177015-72-3 1-bromo-2-methoxy-4-((E)-2-nitro-vinyl)-benzene 
• 80410-57-7 3-methoxy-4-nitrobenzaldehyde 
• 704-13-2 5-formyl-2-nitrophenol 
• 90151-40-9 4-amino-3-methoxybenzaldehyde 
• 43192-34-3 4-bromo-3-methoxybenzaldehyde 

Downstream Products

• 1254068-19-3 N-(4-bromo-3-methoxyphenethyl)-2-(2,3,4-trimethoxyphenyl)acetamide 
• 1256777-38-4 N-[2-(4-bromo-3-methoxy-phenyl)-ethyl]-formamide 
• 1256777-96-4 (S)-N-[2-(4-bromo-3-methoxy-phenyl)-ethyl]-2-formylamino-3,3-dimethyl-butyramide 
• 1256777-39-5 1-Bromo-4-(2-isocyano-ethyl)-2-methoxy-benzene 
• 1256777-40-8 N-[2-(4-bromo-3-methoxy-phenyl)-ethyl]-2-formylamino-2-thiophen-2-yl-acetamide 
• 1428796-07-9 (R)-3-(3-fluorophenyl)-N-(1-hydroxy-3-(1H-indol-3-yl)propan-2-yl)-8-methoxy-9-(pyridin-3-yl)-5,6-dihydropyrrolo[2,1-a]isoquinoline-2-carboxamide 
• 1428796-81-9 ethyl 9-ethyl-3-(3-fluorophenyl)-8-methoxy-5,6-dihydropyrrolo[2,1-a]isoquinoline-2-carboxylate 
• 1428796-82-0 9-ethyl-3-(3-fluorophenyl)-8-methoxy-5,6-dihydropyrrolo[2,1-a]isoquinoline-2-carboxylic acid 
• 1428796-08-0 (R)-9-ethyl-3-(3-fluorophenyl)-N-(1-hydroxy-3-(1H-indol-3-yl)propan-2-yl)-8-methoxy-5,6-dihydropyrrolo[2,1-a]isoquinoline-2-carboxamide 
• 1428796-84-2 ethyl 3-(3-fluorophenyl)-8-methoxy-9-(morpholine-4-carbonyl)-5,6-dihydropyrrolo[2,1-a]isoquinoline-2-carboxylate 
• 1428796-85-3 3-(3-fluorophenyl)-8-methoxy-9-(morpholine-4-carbonyl)-5,6-dihydropyrrolo[2,1-a]isoquinoline-2-carboxylic acid 
• 1428796-12-6 (R)-3-(3-fluorophenyl)-N-(1-hydroxy-3-(1H-indol-3-yl)propan-2-yl)-8-methoxy-9-(morpholine-4-carbonyl)-5,6-dihydropyrrolo[2,1-a]isoquinoline-2-carboxamide 
• 1428796-73-9 N-(4-bromo-3-methoxyphenethyl)acetamide 

Relevant articles and documents

Investigation of the 2,5-Dimethoxy Motif in Phenethylamine Serotonin 2A Receptor Agonists

The 2,5-dimethoxyphenethylamine (2,5-PEA) scaffold is recognized as a motif conferring potent agonist activity at the serotonin 2A receptor (5-HT2AR). The 2,5-dimethoxy motif is present in several classical phenethylamine psychedelics such as 2

PHARMACEUTICAL COMPOUNDS

This invention relates to compounds that inhibit or modulate the activity of Chk-1 kinase. Also provided are pharmaceutical compositions containing the compounds and the therapeutic uses of the compounds.

FSH RECEPTOR ANTAGONISTS

The invention relates to FSH receptor antagonist according to general formula (I) or a pharmaceutically acceptable salt thereof and to a pharmaceutical composition containing the same. The compounds can be used for the treatment and prevention of endometriosis, for the treatment and prevention of pre-menopausal and peri-menopausal hormone-dependent breast cancer, for contraception, and for the treatment of uterine fibroids and other menstrual-related disorders

(DIHYDRO) IMIDAZOISO (5, 1-A) QUINOLINES AS FSH RECEPTOR AGONISTS FOR THE TREATMENT OF FERTILITY DISORDERS

The invention relates to imidazoiso[5,1-a]quinoline and 5,6-dihydro-imidazoiso[5,1-a]quinoline derivatives according to general Formula (1) or a pharmaceutically acceptable salt thereof. The compounds can be used for the treatment of infertility.

(DIHYDRO)IMIDAZOISO[5,1-A]QUINOLINES

The invention relates to imidazoiso[5,1-a]quinoline and 5,6-dihydro-imidazoiso[5,1-a]quinoline derivatives according to general Formula I or a pharmaceutically acceptable salt thereof. The compounds can be used for the treatment of infertility.

(DIHYDRO)PYRROLO[2,1-A]ISOQUINOLINES

The invention relates to 5,6 - dihydropyrrolo [2,1-a] isoquinoline and pyrrolo[2,1-a] isoquinoline derivatives according to general formula (I) or a pharmaceutically acceptable salt thereof. The compounds can be used for the treatment of infertility.

1-Phenyl-3-benzazepine compounds and medicaments containing these compounds for treating gastrointestinal motility disorders

Compounds of the formula (I) and pharmaceutically acceptable acid addition salts thereof for use in treating gastrointestinal motility disorders are described wherein R1 is hydrogen. C1-C6alkyl or C3-C5alkenyl;

1-phenyl-3-benzazepines and their use for treating gastrointestinal motility disorders

1-Phenyl-3-benzazepine compounds are useful in treating gastrointestinal motility disorders. A particular compound of this invention is 8-hydroxy-3-methyl-1-phenyl-7-phenylthio-2,3,4,5-tetrahydro-1H-3-benzazepine.